MABVAX THERAPEUTICS (OTCMKTS:MBVX) is making an explosive move up after the Company announced it, collectively with OPKO Health, Inc. OPK, -0.12% approved the release of $3.5 million in funds held in escrow from the $11.7 million financing the Company completed on April 10, 2015.
In consideration for the release of $3.5 million to MabVax, the Company agreed to give OPKO the right, but not the obligation, until June 30, 2016, to nominate and appoint up to two additional members to the Company’s board of directors; or the Company may nominate and OPKO shall approve in writing the person(s) so nominated by the agreement. Nominees will be subject to satisfaction of standard corporate governance practices and any applicable national securities exchange requirements.
It is easy to get excited about MBVX here; the Company has discovered a unique way to identify fully human monoclonal antibodies – the wholly grail of cancer research. Already the Company has the rights to 8 cancer vaccines.
The big story on MBVX is billionaire Dr. Phillip Frost $11.6 million investment in the Company; the man is a self-made billionaire with a keen eye on bb’s with big futures (check out COCP and DRNE) and he regularly receives national media attention from the likes of Bloomberg, CNBC and Barron’s.
MABVAX THERAPEUTICS (OTCMKTS:MBVX) is a cancer immunotherapy company focused on the development of vaccine and antibody-based therapies to address unmet medical needs in the treatment of cancer.
MabVax has the exclusive license to the therapeutic vaccines from Memorial Sloan Kettering Cancer Center. MabVax has two cancer vaccines targeting recurrent sarcoma and ovarian cancer in proof of concept Phase II multi-center clinical trials, and a vaccine targeting neuroblastoma ready for Phase II clinical development.
The Company takes a unique approach to identifying the elusive cancer antigen proteins that are effective in fighting cancer. This is the holy grail of cancer research and cancer fighting monoclonal antibodies such as the ones that MBVX is creating have been some of the most significant biotechnology products in the last 10 years generating billions of dollars in sales with products such as Herceptin, Rituxan, and Avastin.
MabVax’s lead product is a monoclonal antibody called 5B1 and all results coming back have been highly promising thus far. 5B1 was derived from a patient with stage IV breast cancer who was vaccinated in 2008 and has remained disease free for over 5 years now. MBVX is quickly moving 5B1 forward as an imaging agent, a naked antibody therapeutic, and an antibody drug conjugate.
Also important to note here is that Juno Therapeutics, an oncology giant trading at a $3.5 billion plus market valuation has been evaluating MabVax’s antibody library for potential use in novel chimeric antigen receptor (CAR) T cells.
To Find out the inside Scoop on MBVX Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
On April 6 MBVX announced it has closed on gross proceeds of approximately $11.6 million in a private placement led by OPKO Health, Inc. and Dr. Phillip Frost, CEO and Chairman of OPKO Health.
Pursuant to the Private Placement, MabVax issued a total of 15,486,001 units at $0.75 per unit for total gross proceeds of $11,614,501 before issuance costs of approximately $500,000. Each Unit consists of one share of common stock and a 30-month warrant to purchase one-half of one share of common stock (the “Warrant”). The Warrants are exercisable at $1.50 per each whole share of common stock. Laidlaw & Company (UK) Ltd. acted as an advisor on the transaction.
Mabvax CEO David Hansen said ”This financing will provide MabVax with funds to advance our pipeline of clinical products through several key milestones, and allow us to pursue additional preclinical research programs in our pipeline of which several are partnered with Memorial Sloan Kettering Cancer Center. We are proud to have OPKO Health and biotech investor and entrepreneur, Dr. Phillip Frost, lead the financing. Their input will be invaluable as MabVax advances its business plan.”
Dr. Phillip Frost said “The target for MabVax’s first novel human antibody addresses important medical problems in need of better therapeutic solutions. The early data for its HuMab 5B1 antibody are encouraging and MabVax has a pipeline of dozens of novel antibody leads on its discovery platform from which it may select promising candidates to develop through clinical trials.”
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $5 million market valuation MBVX might just be the most exciting opportunity in small caps today. The Company takes a unique approach to identifying the cancer antigens that are the holy grail of cancer research. Continued success of MBVX lead product 5B1 and current valuation or anywhere near it could be history. Dr. Phillip Frost $11.6 million investment is another huge vote of confidence. We will be updating on MBVX when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with MBVX.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in MBVX either long or short and we have not been compensated for this article.
Frontera Group Inc (OTCMKTS: FRTG) is making an explosive move northbound in recent trading and is currently under heavy accumulation but still unnoticed by most investors. This is changing quickly as some heavy hitters have jumped on FRTG. The Company is only trading for a $2.7 total valuation with a float of just 3,280,000 FRTG is an SEC filer looking to uplist to OTCQB with a 10k coming out any day. From current levels FRTG has a lot of room to grow. Recently Frontera signed a marketing agreement with Long Side Ventures LLC, following an earlier marketing agreement with Stephen Steen on April 27, 2022.
Earlier this year FRTG acquired intellectual property rights from Intellimiedia Networks, Inc., for $5 million in cash and 20 million shares of FRTG. According to the 8k FRTG plans to raise $12 million by year end 2023. Essentially, Intellimedia turned over its assets and Intellectual Properties to Frontera, as Frontera has the platform in place to maximize the value of the purchased IP. Intellimedia Networks is a US and India-based technology company that designs and deploys cloud platforms and applications that create immersive experiences. Intellimedia’s award-winning products utilize AR, VR, and AI to enhance media, training, education, virtual event broadcasting, real estate, and other applications. Frontera brought on business execs Teodros Gessesse and Darshan Sedani.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Frontera Group Inc (OTCMKTS: FRTG) is a strategic acquirer of intellectual property and revenue-generating companies in the technology and human capital markets. It is developing and executing an aggressive, four-tier acquisition and implementation strategy intended to provide substantial increases in profitability to its acquisitions in industries which possess traditionally low and stagnant EBITDA multiples. The Company has identified and is currently pursuing several revenue-generating acquisition targets.
Earlier this year FRTG acquired intellectual property rights from Intellimiedia Networks, Inc., for $5 million in cash and 20 million shares of FRTG. According to the 8k FRTG plans to raise $12 million by year end 2023. Essentially, Intellimedia turned over its assets and Intellectual Properties to Frontera, as Frontera has the platform in place to maximize the value of the purchased IP. Intellimedia Networks is a US and India-based technology company that designs and deploys cloud platforms and applications that create immersive experiences. Intellimedia’s award-winning products utilize AR, VR, and AI to enhance media, training, education, virtual event broadcasting, real estate, and other applications.
In connection with the acquisition Teodros Gessesse was appointed as the Chief Marketing Officer of the Company. Mr. Gessesse’s initial annual base salary will be $150,000. Mr. Gessesse will be eligible to receive a quarterly bonus as determined by, and within the sole discretion of, the BOD and was granted 23,500,000 shares of FRTG. Also, Darshan Sedani was appointed as the Chief Visionary Officer of the Company. Mr. Sedani’s initial annual base salary will be $150,000. Mr. Sedani will be eligible to receive a quarterly bonus as determined by, and within the sole discretion of, the BOD and was granted 31,500,000 shares of FRTG. The deal closed on August 17.
$FRTG Our primary objective: To deliver substantial increases in profitability to our acquisitions in mature industries which possess traditionally low and stagnant EBITDA multiples. pic.twitter.com/eTZ6MoHOmE
To Find out the inside Scoop on FRTG Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
In June FRTG released the 3.0 version of its Mixie Holoport immersive reality framework with Extended Reality (XR) support (“Mixie Holoport XR”). Mixie Holoport XR is a National Association of Broadcasters (NAB) Product of the Year award winner, setting the benchmark for immersive realism in Augmented Reality (AR), Mixed Reality (MR), and Virtual Reality (VR) applications. Frontera recently acquired the Mixie Holoport IP to enhance Metaverse business applications.
Frontera also launched its Mixie AI 2.0 powered live video broadcasting solution that will be targeting automated broadcasting applications. Frontera’s recent acquisition of Intellimedia’s Mixie suite of solutions has provided Frontera with a cutting-edge mix of media technology, learning and training platforms, and event broadcasting technologies that position the company at the technology forefront of a new wave of immersive and engaging technologies that continue to redefine applications. Intellimedia’s Mixie AI 2.0 solutions were utilized for Cricket AI Tata Open Tournament and the ISSF Shooting World Championship to simplify and automate the capture, analysis, discovery, and broadcast of both events. The resulting professional broadcast quality and dramatic cost reduction have become a wake-up call for both organizations to stage and broadcast future events.
Earlier this month FRTG reported it has commenced commercial sales and marketing efforts of Immersient, the intellectual property which was acquired from IntelliMedia Networks, Inc. and formerly sold under the Mixie brand name. Now sold and marketed under the Immersient brand, Frontera’s cloud media platform connects content producers, educational institutions, and event producers with participants and viewers, delivering immersive, personal experiences, interactive participation, existing device compatibility, familiar user conventions, and reliable, “always available” service. The Immersient cloud media platform allows its clients to focus on their core businesses, knowing their end users are enjoying state-of-the-art experiences. With its frictionless device and network independent approach to immersive virtual, augmented, and mixed reality environments, Immersient delivers next-generation group collaboration and communications, interactive distance learning and training, and virtualized events, meetings, expos, conferences, and trade shows.
Currently trading at a $2,7 million market valuation FRTG has 55,563,482 shares outstanding and just 3,280,000 shares in the float. The Company has a clean balance sheet and recently filed a 10Q with a 10k on the way and looking to uplist to OTCQB. FRTG is an exciting story developing in small caps; earlier this year FRTG acquired intellectual property rights from Intellimiedia Networks, Inc., for $5 million in cash and 20 million shares of FRTG. According to the 8k FRTG plans to raise $12 million by year end 2023. Essentially, Intellimedia turned over its assets and Intellectual Properties to Frontera, as Frontera has the platform in place to maximize the value of the purchased IP. Earlier this month FRTG reported it has commenced commercial sales and marketing efforts of Immersient, the intellectual property which was acquired from IntelliMedia Networks, Inc. and formerly sold under the Mixie brand name. Now sold and marketed under the Immersient brand, Frontera’s cloud media platform connects content producers, educational institutions, and event producers with participants and viewers, delivering immersive, personal experiences, interactive participation, existing device compatibility, familiar user conventions, and reliable, “always available” service. The stock is currently under heavy accumulation, with big momentum, a little float and some well-known investors jumping on board. We will be updating on FRTG when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with FRTG.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in FRTG either long or short and we have not been compensated for this article.
CV Sciences Inc (OTCMKTS: CVSI) is making an explosive move up the charts after the Company announced in a press release and 8K it has extinguished its entire outstanding convertible debt. This is massive news for CVSI which was the number #1 CBD brand on the market but struggled because of the Company’s significant convertible debt load which diluted the stock. That has all been extinguished now and CVSI is racing up the charts. CVSI was one of the biggest runners of 2018 skyrocketing from pennies to over $9 per share when PlusCBD™ sales were booming and the Nasdaq uplist seemed to be around the corner. That all collapsed however not because CVSI was not making sales, they were, but because the Company had significant convertible debt that was decimating the share price.
CVSI is racing up the charts just a penny over all-time lows of $0.0275 and it has a lot of room to grow from current levels. Remember CVSI was one of the biggest runners of 2018 skyrocke3ting to over $9 per share. CVSI is still doing big numbers; Second Quarter 2022 and Recent Financial and Operating Highlights include Revenue of $4.1 million for second quarter of 2022 putting the Company on track to easily top $16 million in sales during fiscal 2022. CVSI is an SEC filer and fully reporting OTCQB and reports its filings in 1000s just like big board Companies do. Now that CVSI has solved the biggest problem that held back its stock for years, currently trading a few pennies over sll time lows and sales as strong as ever speculators are heavily accumulating CVSI and for very good reason, this one ran to over $9 in 2018 and sales are strong with CVSI recently reporting Revenue of $4.1 million for second quarter of 2022.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
CV Sciences Inc (OTCMKTS: CVSI) is a consumer wellness company specializing in hemp extracts and other proven, science-backed, natural ingredients and products, which are sold through a range of sales channels from B2B to B2C. The Company’s PlusCBD™ branded products are sold at select retail locations throughout the U.S. and are one of the top-selling brands of hemp extracts in the natural products market, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry. CV Sciences follows all guidelines for Good Manufacturing Practices (GMP) and the Company’s products are processed, produced, and tested throughout the manufacturing process to confirm strict compliance with company standards and specifications. With a commitment to science, PlusCBD™ product benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov. PlusCBD™ was the first hemp extract supplement brand to invest in the scientific evidence necessary to receive self-affirmed Generally Recognized as Safe (GRAS) status. CV Sciences, Inc. has primary offices and facilities in San Diego, California. The Company also operates a drug development division focused on developing and commercializing CBD-based novel therapeutics.
CVSI is still doing big numbers; Second Quarter 2022 and Recent Financial and Operating Highlights include Revenue of $4.1 million for second quarter of 2022, compared to $5.1 million for the second quarter of 2021; Total cash balance of $1.1 million at quarter end, compared to $1.4 million at year end; During Q2 CVSI launched PlusCBD™ Relief softgels to its wellness line of products joining our successful PlusCBD™ Sleep and Calm gummies; the Company Regained position as top-selling hemp extract brand in the natural product retail sales channel, according to SPINS, the leading provider of syndicated data and insights for the natural, organic and specialty products industry; CVSI Continued to evaluate strategic review, including consideration of inbound and outbound merger, sale, acquisition or other options for the Company as a whole or for any business segments anc completed a move to more efficient and cost effective facility in San Diego.
To Find out the inside Scoop on CVSI Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
On August 25 CVSI announced it has extinguished its entire outstanding convertible debt. This is massive news for CVSI which was the number #1 CBD brand on the market but struggled because of the Company’s significant convertible debt load which diluted the stock. That has all been extinguished now. CV Sciences entered into a Note Purchase Agreement with Streeterville Capital, LLC, in which the Company issued and sold to Streeterville a Secured Promissory Note in the original principal amount of $2,000,000. The Note carries an original issuance discount of $400,000 and the Company agreed to pay $10,000 to Streeterville to cover legal fees, each of which were deducted from the proceeds of the Note received by the Company which resulted in a purchase price received by the Company of $1,590,000. The unpaid amount of the Note, any interest, fees, charges and late fees accrued shall be due and payable in full nine months from August 19, 2022. The Note Agreement required that the Company cancel and terminate the existing Senior Convertible Note dated March 25, 2022 (the “3i Note”) between the Company and 3i, LP (“3i, LP”) in the original principal amount of $1,060,000.
CVSI CEO Joseph Dowling stated: “We have retired all of our outstanding convertible debt which strengthens our balance sheet and helps us with our long-term strategic initiatives. The termination of all convertible debt and related obligations to issue stock to our lender will eliminate the dilutive impact of this debt on our stockholders. In addition, the termination of our convertible debt will eliminate the downward pressure on our stock caused by sale of the shares issued at each conversion event. Our focus is to support our business goals that build shareholder value, and in this regard, we believe eliminating the negative impact of this financing is just as important as continuing to grow our PlusCBD™ branded products business.”
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $4 million market valuation CVSI was one of the most exciting stocks on the OTCBB making spectacular moves up in 2018 to over $9.20 per share before collapsing on the Citron Research short attack. Currently CVSI is making an explosive move up the charts after the Company announced in a press release and 8K it has extinguished its entire outstanding convertible debt. This is massive news for CVSI which was the number #1 CBD brand on the market but struggled because of the Company’s significant convertible debt load which diluted the stock. That has all been extinguished now and CVSI is racing up the charts. CVSI was one of the biggest runners of 2018 skyrocketing from pennies to over $9 per share when PlusCBD™ sales were booming and the Nasdaq uplist seemed to be around the corner. CVSI is racing up the charts just a penny over all-time lows of $0.0275 and it has a lot of room to grow from current levels. CVSI was one of the biggest runners of 2018 skyrocke3ting to over $9 per share. CVSI is still doing big numbers; Second Quarter 2022 and Recent Financial and Operating Highlights include Revenue of $4.1 million for second quarter of 2022 putting the Company on track to easily top $16 million in sales during fiscal 2022. CVSI is an SEC filer and fully reporting OTCQB and reports its filings in 1000s just like big board Companies do. Now that CVSI has solved the biggest problem that held back its stock for years, currently trading a few pennies over all-time lows and sales as strong as ever speculators are heavily accumulating CVSI and for very good reason, this one ran to over $9 in 2018 and sales are strong with CVSI recently reporting Revenue of $4.1 million for second quarter of 2022. Now that its convertible debt is out of the way CVSI could make another real move. We will be updating on CVSI when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with CVSI.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in CVSI either long or short and we have not been compensated for this article.
DSG Global Inc (OTCMKTS: DSGT) is making an explosive move up the charts in recent trading since moving northbound off its $0.05 base. The stock is under heavy accumulation and is quickly getting noticed by investors. DSGT has a long history of big moves running from well under a dime (where we first reported on it in November 2020 when the stock was $0.07) to highs of $1.51 in December 2020. Currently running northbound DSGT stated in their latest press release they hired ICON Capital Group to be the financial advisor and broker-dealer on a potential spinout of subsidiary Imperium Motor Corp. Potential structures can include an IPO, a merger with an existing NASDAQ company, or a SPAC merger. DSGT management is focused on finding the best way to position Imperium Motors in the EV space that will allow the Company to have the greatest impact in the booming EV space.
DSGT is doing big numbers; Revenue for Q2 totaled $1,174,878 compared to $494,838 for Q2 2021, an increase of $680,040 or 137%. The increase was a result of new installation of Infinity system and delivery of the first 5 containers of Vantage Pro fleet golf carts. As of June 30, the company had $2.75 million in signed orders, inclusive of recurring revenue, on the GPS tracking system. As inventory becomes available DSG expects to satisfy this backlog during the third quarter of 2022. Also as of June 30, the company had a strong pipeline of sales on the newly introduced Vantage golf cart line up including the 9 containers of Vantage Pro fleet carts with 5 delivered and the balance 4 containers arriving in 10 days. A further 2 containers of Shelby golf carts have been ordered with a further 4 containers in the system to be ordered. This pipeline exceeds more than $14 million. The company has received over 2200 refundable deposits for the SEV electric vehicle and continues a good working relationship with Skywell to complete the homologation process. “Our current placed refundable deposits on the SEV electric vehicle represents approximately $88 million in bookable revenue once product is delivered” said Robert Silzer, CEO of DSG Global.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
DSG Global Inc (OTCMKTS: DSGT) is a technology development company based in Surrey, British Columbia, Canada, engaged in the design, manufacture, and marketing of fleet management solutions for the golf industry, as well as commercial, government and military applications. In 2020, DSG established an electric vehicle marketing and distribution division, Imperium Motor Company, and in 2021 the Company formed a golf cart division, AC Golf Carts, Inc. with exclusive world-wide rights of Shelby Cobra golf carts. The principal activities of our fleet management and golf division are the development, sale and rental of GPS tracking devices and interfaces for golf vehicles, and related support services. More recently, DSG subsidiary Vantage Tag (Vantage) expanded from its original purpose of producing and marketing GPS systems, to leading DSG’s golf industry presence by supplying a comprehensive package of electric vehicles, fleet management systems, and back of house support services to the golf industry, and to commercial customers in the last mile delivery, tourism and resort, education, agriculture, and corporate markets. Meanwhile, DSG electric vehicle division is engaged in the importation, marketing and distribution of a range low-speed and high-speed electric passenger vehicles for commuter, family, commercial, and public use.
Vantage Tag Systems (VTS) provides patented electronic tracking systems and fleet management solutions to golf courses and other venues that allow for remote management of the course’s fleet of golf carts, turf equipment and utility vehicles. Its clients use VTS’ unique technology to significantly reduce operational costs, improve the efficiency plus profitability of their fleet operations, increase safety and enhance customer satisfaction. VTS has grown to become a leader in the category of fleet management in the golf industry, with their technology installed in vehicles worldwide. VTS is now branching into several new streams of revenue through programmatic advertising, licensing, and distribution, as well as expanding into commercial fleet management, single rider golf carts, the new Lithium Vantage Golf Carts, and agricultural applications.
DSG was founded by a group of individuals who have dedicated their careers to fleet management technologies and have been at the forefront of the industry’s most innovative developments. The Company’s executive team has over 50 years of experience in the design and manufacture of wireless, GPS, and fleet tracking solutions, and over 40 years automotive retail, wholesale, distribution, and manufacturing.
To Find out the inside Scoop on DSGT Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
On August 8 DSG reported Second Quarter 2022 Financial Highlights: Revenue for Q2 totaled $1,174,878 compared to $494,838 for Q2 2021, an increase of $680,040 or 137%. The increase was a result of new installation of Infinity system and delivery of the first 5 containers of Vantage Pro fleet golf carts.
As of June 30, the company had $2.75 million in signed orders, inclusive of recurring revenue, on the GPS tracking system. As inventory becomes available DSG expects to satisfy this backlog during the third quarter of 2022.
Also as of June 30, the company had a strong pipeline of sales on the newly introduced Vantage golf cart line up including the 9 containers of Vantage Pro fleet carts with 5 delivered and the balance 4 containers arriving in 10 days. A further 2 containers of Shelby golf carts have been ordered with a further 4 containers in the system to be ordered. This pipeline exceeds more than $14 million.
The company has received over 2200 refundable deposits for the SEV electric vehicle and continues a good working relationship with Skywell to complete the homologation process. “Our current placed refundable deposits on the SEV electric vehicle represents approximately $88 million in bookable revenue once product is delivered” said Robert Silzer, CEO of DSG Global.
On August 25 DSGT announced it has retained ICON Capital Group to be the financial advisor and broker-dealer on a potential spinout of the Company’s wholly owned subsidiary Imperium Motor Corp. Potential structures can include an IPO, a merger with an existing NASDAQ company, or a SPAC merger.
The expectation is that DSG will remain a minority shareholder in the new entity and in addition, the Company intends to dividend out to the current shareholders of record (on a TBD record date) a portion of the shares in the new entity and ongoing annual dividends. By doing so, the new entity will have a unique, deep shareholder base, unlike many new listings trading on national exchanges. Management of Imperium will stay in place and a recruiting initiative for a North American automotive executive to head the public entity is underway. The EV industry is poised for substantial and sustained growth. Electric vehicles will account for about half of auto sales in the world’s major markets by 2030 as sticker prices reach parity with gasoline-fueled cars, according to a survey of automotive executives.
Bob Silzer, CEO DSG Global Inc. stated: “We are pleased to secure Icon Capital Group as our financial advisors to facilitate the transaction and guide the company to the best path to unlock shareholder value. We believe our story has not been properly digested in the marketplace, undervalued, and realizing our EV business needs to be appropriately scaled as a stand-alone company therefore enjoying the publicity it deserves. Also, DSG’s Imperium Motor Company had substantial additional expenses incurred by DSG Global that will be off the books and capturing full repayment of all expenses. With the recent legislative tail wind for EVs because of the Inflation Reduction Act just passed in the US, we feel like this is the proper time to make a concerted effort to ensure value for our shareholders and allow DSG management to focus on our core GPS and Golf Cart business, both of which are experiencing tremendous growth. These favorable market conditions and our unique business model inside of Imperium is truly differentiating and will be well received as a stand-alone entity. As an exclusive distributor for North America for high quality EV’s requires considerably less capital than most EV companies in the public space, and financial resources can be dedicated to marketing and sales that drive immediate revenue. We intend to have vehicles through homologation and ready for delivery in the coming months.”
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $19 million market valuation DSGT OS is 141,865,636 shares with 114,089,611 shares in the float. DSGT is an SEC filer and fully reporting OTCQB with $1.5 million in the treasury and about $6 million in liabilities. Currently the stock is under heavy accumulation and is quickly getting noticed by investors. DSGT has a long history of big moves running from well under a dime (where we first reported on it in November 2020 when the stock was $0.07) to highs of $1.51 in December 2020. Currently running northbound DSGT stated in their latest press release they hired ICON Capital Group to be the financial advisor and broker-dealer on a potential spinout of subsidiary Imperium Motor Corp. Potential structures can include an IPO, a merger with an existing NASDAQ company, or a SPAC merger. DSGT management is focused on finding the best way to position Imperium Motors in the EV space that will allow the Company to have the greatest impact in the booming EV space. DSGT is doing big numbers; Revenue for Q2 totaled $1,174,878 compared to $494,838 for Q2 2021, an increase of $680,040 or 137%. The increase was a result of new installation of Infinity system and delivery of the first 5 containers of Vantage Pro fleet golf carts. As of June 30, the company had $2.75 million in signed orders, inclusive of recurring revenue, on the GPS tracking system. As inventory becomes available DSG expects to satisfy this backlog during the third quarter of 2022. Also as of June 30, the company had a strong pipeline of sales on the newly introduced Vantage golf cart line up including the 9 containers of Vantage Pro fleet carts with 5 delivered and the balance 4 containers arriving in 10 days. A further 2 containers of Shelby golf carts have been ordered with a further 4 containers in the system to be ordered. This pipeline exceeds more than $14 million. The company has received over 2200 refundable deposits for the SEV electric vehicle and continues a good working relationship with Skywell to complete the homologation process. “Our current placed refundable deposits on the SEV electric vehicle represents approximately $88 million in bookable revenue once product is delivered” said Robert Silzer, CEO of DSG Global. We will be updating on DSGT when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with DSGT.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in DSGT either long or short and we have not been compensated for this article.